Brashears, Caitlyn B.
Barlin, Meltem
Ehrhardt, William R.
Rathore, Richa http://orcid.org/0000-0003-3708-8758
Schultze, Matthew
Tzeng, Shin-Chen
Van Tine, Brian A. http://orcid.org/0000-0003-4572-6668
Held, Jason M. http://orcid.org/0000-0001-8024-2736
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Cancer Institute (RO1 CA227115)
CJ’s Journey, The Sarcoma Foundation of America, The Sarcoma Alliance for Research and Collaboration, nd The Josephine Norcia Riley Angiosarcoma Awareness Inc. Grant
Article History
Received: 11 February 2020
Revised: 29 July 2020
Accepted: 30 July 2020
First Online: 20 August 2020
Conflict of interest
: Van Tine BA reports basic science grant funding from Pfizer, Tracon, and Merck; consulting fees from Epizyme, Lilly, CytRX, Janssen, Immune Design, Daiichi Sankyo, Plexxicon, and Adaptimmune; speaking fees from Caris, Janseen, and Lilly; and travel support from Lilly, GSK, and Adaptimmune. Schultze M. reports employment and stock options from ADRx, Inc. J.H. acknowledges funding and support from AB SCIEX. Remaining authors report no conflict of interests.